Примери за използване на Insulin-producing на Английски и техните преводи на Български
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Scientists have discovered that Type 1 diabetes not only destroys insulin-producing cells, but also blood vessels that support them.
Type 2 diabetes does not involve the attack of insulin-producing cells led by GAD antibodies.
Islet cell cytoplasmic autoantibodies(ICA)- these antibodies also result in insulin-producing cells being attacked.
cells to mature and function like regular insulin-producing cells do.
viruses- mistakenly destroys the insulin-producing cells in your pancreas.
They have been trying to produce stable, insulin-producing cells for years, and you did it.
Islet autoimmunity is a process wherein the immune system mistakingly attacks the insulin-producing cells of the pancreas,
Moreover, insulin-producing cells must work very hard to maintain a normal blood sugar level.
Antibodies recognizing the molecular signatures of mycobacterium paratuberculosis cross-react with the molecular signatures present on our insulin-producing beta cells in our pancreas.
one of the root causes of diabetes(beware: inflammation destroys the insulin-producing beta cells in the pancreas).
They also found that 40% of adults with type 2 diabetes had signs of the infection in insulin-producing cells.
therefore easier to transform into insulin-producing cells than the newer induced pluripotent stem cells(iPSCs),
Scientists have discovered that one of the most diabolical proteins implicated in diabetes not only kills insulin-producing cells through one mechanism, but also damages the cells it doesn't kill through a second, novel mechanism.
have claimed that they are the first to turn human stem cells into the mature, insulin-producing cells that type 1 patients don't have.
One reason the latest research is so promising is that insulin-producing cells are better at regulating blood sugar than an injection,
e.g., insulin-producing cells in diabetes or dopaminergic neurons in Parkinson's disease.
Pharmaceutical giant has disclosed that starting a new project with Cellartis- a private biotechnology company developing drugs to treat diabetes type-1 by reprogramirane of stem cells into insulin-producing cells.
they can be induced to become cells with special functions such as the beating cells of the heart muscle or the insulin-producing cells of the pancreas.
Rosengren and colleagues compared insulin-producing beta cells from diabetics with those of non-diabetics,
our findings could also lead to new methods of treating type 2 diabetes by developing ways of blocking the protein SFRP4 in the insulin-producing beta cells